CAS: 2040291-27-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LLY-283 REF: 4Z-K-031050CAS: 2040291-27-6 | - - - | To inquire | Mon 10 Mar 25 |
 | LLY 283 REF: 3D-BL166665CAS: 2040291-27-6 | Min. 95% | 2,965.00 € | Mon 14 Apr 25 |
 | LLY-283 REF: TM-T15767CAS: 2040291-27-6 | 98.79% | To inquire | Mon 02 Jun 25 |
Ref: 4Z-K-031050
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 10 Mar 2025
LLY 283
CAS:2040291-27-6
SAM-competitive PRMT5 enzyme inhibitor
Formula:
C17H18N4O4
Purity:
Min. 95%
Molecular weight:
342.35 g/mol
Ref: 3D-BL166665
| 100mg | 2,965.00 € |
Estimated delivery in United States, on Monday 14 Apr 2025
LLY-283
CAS:2040291-27-6
LLY-283, PRMT5 inhibitor, IC50 22 nM, Kd 6 nM, oral, selective, with antitumor effects.
Formula:
C17H18N4O4
Purity:
98.79%
Color and Shape:
Solid
Molecular weight:
342.35
Ref: TM-T15767
| 1mg | 40.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | To inquire | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 2 Jun 2025
